Figure 5. Mutation analysis of two different prognostic risk score groups. Oncoplot of top 20 high frequency of mutated genes in LRPS-group/low-risk group (A) and HRPS-group/high-risk group (B). The major mutation-enriched pathways in LRPS-group/low-risk group (C) and HRPS-group/high-risk group (D). Difference of mutated genes (E) and TMB score (F) in two different PRS groups.